TCS Partners with Dassault Systems to Develop Digital Heart Models

Tanushree Jaiswal Tanushree Jaiswal 12th September 2023 - 05:47 pm
Listen icon

Tata Consultancy Services (TCS) shares price gained by nearly 1% to reach ₹3,500 in early trade on September 12. This surge follows TCS's announcement of a partnership with Dassault Systems, aimed at driving digital transformation within the realm of cardiovascular science through bio-physical simulation.

Digital Transformation in Cardiovascular Science

Tata Consultancy Services (TCS) revealed in an exchange filing on September 11 that it will join forces with Dassault Systemes and other collaborators to embark on a visionary mission the creation of a Virtual Human Twin. This endeavor will concentrate on specific organs considered pivotal in advancing the field of medical science.

TCS's core goal is to create and authenticate highly realistic digital simulations of the human heart. These simulations will serve as digital evidence for the approval of innovative cardiovascular devices. One notable application of this technology is an in-silico clinical trial, which has the potential to supplement the data gathered from traditional clinical subjects. Furthermore, this approach promises to reduce the necessity for animal testing and minimize the need for human enrollment in clinical trials.

Dassault Systemes - A Leading Force in Virtual Experiences

Dassault Systemes is renowned for its cutting-edge software solutions that empower customers to create innovative products and services using virtual experiences. By collaborating with Dassault Systemes, TCS is poised to revolutionize the field of cardiovascular science and pave the way for more efficient and ethical medical advancements.

Leaders' Perspectives

Steve Levine, Senior Director of Virtual Human Modeling at Dassault Systèmes and founder of The Living Heart Project, expressed enthusiasm for the collaboration, emphasizing its potential to advance medical science and patient care. Levine stressed the significance, stating, "Their vast expertise in research and technology development will offer invaluable insights to our mission and to fellow researchers within the industry." This partnership underscores our mutual dedication to harnessing the potential of the virtual realm to propel the progress of medical science and enhance patient care. Through our collaboration, we are confident in our ability to expedite innovation and achieve substantial advancements in our pursuit of crafting and delivering customized in-silico medical solutions."

Tata Consultancy Services (TCS), a renowned global leader in IT services and consulting, is eagerly looking forward to making a valuable contribution to the Living Heart initiative. Vikram Karakoti, who serves as the Global Head of the Life Sciences Business at TCS, emphasized the pivotal role of this partnership in advancing our comprehension of cardiac function. He also highlighted the potential to support innovative treatments for cardiac conditions and facilitate the development of new products in the medical technology and pharmaceutical sectors.

Karakoti articulated TCS's enthusiasm for participating in the Living Heart initiative and collaborating to develop a groundbreaking digital simulation of the human heart. This initiative is expected to enhance our understanding of cardiac function and offer insights that can lead to innovative treatments and the creation of novel products in the fields of medical technology and pharmaceuticals. TCS believes that its extensive experience in constructing digital bio-twin models for various organs and body parts positions the company effectively to make substantial contributions to this collaborative effort.

A Parallel Endeavor with Jaguar Land Rover

In parallel, TCS has also made waves in the automotive sector. The company recently inked a significant agreement with Jaguar Land Rover (JLR), a wholly-owned subsidiary of Tata Motors, where Tata Sons holds the majority stake.

The deal with JLR carries a substantial valuation of £800 million ($1 billion) over the next five years. Under this agreement, TCS will play a pivotal role in helping JLR transform, simplify, and manage its digital services. The partnership will also involve the creation of a forward-looking, strategic technology architecture, aligning with JLR's "Reimagine" strategy.

This strategic partnership underscores TCS's commitment to pushing the boundaries of technology and innovation across diverse industries, from cardiovascular science to the luxury automotive sector. With a relentless focus on digital transformation, TCS continues to shape a future where cutting-edge solutions drive progress and impact the world positively.


 

How do you rate this article?

Characters remaining (1500)

Disclaimer: Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.

FREE Trading & Demat Account
+91
''
Resend OTP
''
''
Please Enter OTP
''
By proceeding, you agree T&C*
Mobile No. belongs to

IPOs Related Articles

HOAC Foods India IPO Lists at +206.25% Premium

by Tanushree Jaiswal 24/05/2024

Quest Laboratories IPO Lists at 59.90% Premium

by Tanushree Jaiswal 23/05/2024

Go Digit IPO Lists at 5.15% Premium on NSE

by Tanushree Jaiswal 23/05/2024

AWFIS Space IPO Subscription Status

by Tanushree Jaiswal 23/05/2024